Showing results (161-170 of 784) with videos related to
Sort By:
Pageof 79
Chest|November 6, 2010
Human γ-herpesviruses Epstein-Barr virus and human herpesvirus-8 are not detected in the lungs of patients with severe pulmonary arterial hypertensionSéverine Valmary, Peter Dorfmüller, David Montani, et al.Vascular Pharmacology|July 9, 2008
Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertensionMarc Humbert, David Montani, Frédéric Perros, et al.Seminars in Respiratory and Critical Care Medicine|July 28, 2009
Idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: similarities and differencesDavid Montani, Kristina Kemp, Peter Dorfmuller, et al.Annales De Medecine Interne|September 10, 2002
[Pulmonary hypertension associated with systemic sclerosis]Olivier Sanchez, Hilario Nunes, Olivier Sitbon, et al.Advances in Therapy|December 15, 2019
Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic AsthmaDavid J Jackson, Marc Humbert, Ian Hirsch, et al.Presse Medicale (Paris, France : 1983)|August 26, 2014
[Treatment of pulmonary arterial hypertension]Olivier Sitbon, Laurent Savale, Xavier Jaïs, et al.Chest|August 15, 2021
Phenotypic Diversity of Vascular Smooth Muscle Cells in Pulmonary Arterial Hypertension: Implications for TherapyBenoit Lechartier, Nihel Berrebeh, Alice Huertas, et al.Expert Review of Respiratory Medicine|April 23, 2011
Pulmonary veno-occlusive disease: advances in clinical management and treatmentsAlice Huertas, Barbara Girerd, Peter Dorfmuller, et al.Presse Medicale (Paris, France : 1983)|May 4, 2011
[Treatment of pulmonary arterial hypertension in 2011: what's new since the 2009 ERS/ESC guidelines?]Laurent Savale, Xavier Jaïs, David Montani, et al.Chest|December 24, 2005
Clinical challenges in pulmonary hypertension: Roger S. Mitchell lectureSteeve Provencher, Xavier Jais, Azzedine Yaici, et al.Pageof 79